Polypeptide from Inner Mongolia dried milk cake as well as preparation method and application thereof
Polypeptides such as YPFPGPIH, IPYVRYL and VMFPPQ were extracted and prepared from Inner Mongolia milk tofu by water extraction and solid phase synthesis, which solved the problem of difficult to screen out polypeptides with both biological activity and taste characteristics in the prior art, and achieved high efficiency , low-cost preparation process and provides new functional ingredients for the food industry.
Patent Information
- Application Number
- CN202410951330.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art is difficult to quickly and effectively screen out polypeptides with both biological activity and taste characteristics, especially polypeptides with antioxidant, antihypertensive and taste characteristics from Inner Mongolia milk tofu, resulting in the lack of alternative condiments and Functional ingredients.
Through water extraction, filtration and amino acid sequence analysis, combined with online databases to predict the biological activity and taste characteristics of the peptide, polypeptides such as YPFPGPIH, IPYVRYL and VMFPPQ were prepared by solid phase synthesis method, achieving polypeptides with both biological activity and taste attributes. Extraction and synthesis.
The successful preparation of polypeptides with good antioxidant activity and ACE inhibitory activity simplifies the preparation process, reduces costs and manpower requirements, and provides potential applications for food flavoring, antioxidants and hypertensive drugs.
Smart Images

Figure CN118909038A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of protein, in particular to a polypeptide derived from Inner Mongolia milk tofu and a preparation method and application thereof. Background Art
[0002] Inner Mongolian milk tofu, also known as Hurood, is a cheese product made from raw milk by ethnic minorities in Inner Mongolia using traditional production processes. Milk tofu is rich in protein, fat, vitamins, trace elements calcium, phosphorus, iron, etc., such as a variety of unsaturated fatty acids including oleic acid and linoleic acid, which can lower cholesterol and prevent cardiovascular disease. Cheese is rich in bioactive peptides. Most of the bioactive peptides identified so far are ACE inhibitory peptides and antioxidant peptides, as well as antimicrobial peptides, antidiabetic peptides, immunomodulatory peptides, opioids, mineral binding peptides, anti-inflammatory peptides, etc.
[0003] In recent years, the number of studies on new functional ingredients from various food sources has increased significantly, especially phenolic compounds, bioactive peptides, etc. Bioactive peptides are low-molecular polymers between proteins and amino acids that have special physiological regulatory functions and are produced during the enzymatic hydrolysis of proteins. They are a general term for peptides ranging from dipeptides to complex linear and ring structures composed of 20 natural amino acids in different compositions and arrangements. Among them, food-derived bioactive peptides refer to oligopeptides released by enzymatic hydrolysis, fermentation or gastrointestinal digestion of proteins from food, which are composed of 2-20 amino acids; bioactive peptides can provide basic nutrition for the body and have a variety of biological functions that are beneficial to human health. At present, common bioactive peptides are antioxidant peptides, antihypertensive peptides, antimicrobial peptides, anti-inflammatory peptides, immunomodulatory peptides, opioid peptides, mineral binding peptides, antidiabetic peptides, antitumor, antithrombotic peptides, etc. At present, biologically active peptides have been isolated and extracted from a variety of foods, such as dairy products, aquatic products, meat, eggs, soybeans, peanuts, flax seeds, cereals, etc., from which antioxidant peptides, antihypertensive peptides, antimicrobial peptides, etc. have been isolated. Bioactive peptides have great development potential, especially in functional foods, such as replacing synthetic antioxidants with natural antioxidants, replacing synthetic angiotensin-converting enzyme inhibitors with natural angiotensin-converting enzyme inhibitors, or replacing synthetic antibiotics with natural antimicrobials, which can have a beneficial effect on the health effects and functions of food systems. In addition to their functional activities, some bioactive peptides can also improve the water retention, foaming, emulsification, stability, viscosity and solubility of products. Bioactive peptides have been shown to have broad prospects in the development of health-oriented functional foods.
[0004] Taste peptides mainly include umami peptides, bitter peptides, salty peptides, sweet peptides, sour peptides and thick peptides. At present, the research on taste peptides mainly focuses on the mining of umami peptides, bitter peptides and thick peptides. At present, since the intake of condiments such as sodium chloride and monosodium glutamate may cause various diseases, there is an urgent need to explore flavor peptides that can replace condiments, such as umami peptides and salty peptides. At the same time, more research focuses on the mining of salty and umami enhancement peptides, thereby playing a role in reducing salt. At present, the conventional taste peptide screening method is mainly to separate and identify taste peptides through a series of technologies such as extraction, ultrafiltration, gel chromatography filtration and high performance liquid chromatography. These methods are time-consuming, high detection cost, and complex operation. Therefore, computer-assisted calculation has become a rapid screening method. The taste characteristics of peptides are predicted through online databases and virtual screening methods. It is efficient, reduces manpower and costs, and speeds up the screening speed and the accuracy and consistency of data. At present, there is no literature report on the use of multiple screening technology to screen and identify taste peptides from Inner Mongolia milk tofu. In addition, some flavor peptides also have certain biological activities such as anti-hypertension, anti-inflammatory and antioxidant capabilities, and have the potential to be used as functional ingredients, so they have broad application prospects in the food industry. At present, there are few studies on peptides that have both flavor and biological activity. Most of the studies are on peptides with unilateral activity, such as life-active peptides or flavor peptides, and there are few reports on peptides that combine the two.
[0005] It can be seen that the prediction and screening of peptides with both biological activity and taste characteristics from Inner Mongolia milk tofu will contribute to the development of food technology and have broad prospects for the production of functional foods, food additives or drugs. Summary of the invention
[0006] The purpose of the present invention is to provide a polypeptide derived from Inner Mongolia milk tofu and a preparation method and application thereof, so as to solve the problems existing in the above-mentioned prior art.
[0007] To achieve the above object, the present invention provides the following solutions:
[0008] One of the technical solutions of the present invention is a polypeptide with antioxidant activity, antihypertensive activity and flavor characteristics derived from Inner Mongolia milk tofu, wherein the multi-active polypeptide is YPFPGPIH, IPYVRYL or VMFPPQ.
[0009] The second technical solution of the present invention is a method for preparing the polypeptide, comprising the following steps:
[0010] Step1. Take Inner Mongolia milk tofu, crush it and set aside;
[0011] Step 2. The ground milk tofu powder is subjected to water extraction to obtain a water-soluble extract;
[0012] Step 3. Filter the water-soluble extract of Inner Mongolia milk tofu and analyze and identify its amino acid sequence;
[0013] Step 4. Calculate the Q value of the identified peptides, predict the umami / bitter and kokumi properties, and use molecular docking to screen peptides that bind to umami, bitter and kokumi receptors to obtain potential flavor peptides;
[0014] Step 5. Input the amino acid sequence of the peptide into the online website ToxinPred to predict the toxicity of the peptide; predict the ACE inhibitory activity using the antihypertensive database; predict the antioxidant activity using the AnOxPP and AnOxPePred online websites; based on the prediction score and taste prediction, screen for potential peptides with both biological activity and taste activity;
[0015] Step 6. Use solid phase synthesis to synthesize the polypeptide with a purity of >98%.
[0016] The third technical solution of the present invention is the use of the polypeptide in the preparation of food flavoring.
[0017] A fourth technical solution of the present invention is the use of the polypeptide in the preparation of antioxidants.
[0018] A fifth technical solution of the present invention is the use of the polypeptide in the preparation of drugs for preventing and treating hypertension.
[0019] The sixth technical solution of the present invention is a product for food seasoning, comprising the polypeptide.
[0020] Based on the above technical solution, the present invention has the following technical effects:
[0021] 1. The present invention synthesized three peptides with both biological activity and flavor properties, namely YPFPGPIH, IPYVRYL and VMFPPQ, which have good antioxidant activity and ACE inhibitory activity. Among them, YPFPGPIH and IPYVRYL present a single bitter taste, while VMFPPQ has a distinct umami taste, as well as a weak bitter taste and a strong feeling. These three active peptides can enrich the flavor of food, especially VMFPPQ has umami taste, which can mask the overall bitterness of food and make the overall taste of the food system mild; in addition, it can be used in the fields of food and medicine, as a base material or auxiliary material for making drugs and health products;
[0022] 2. The present invention proposes a method for preparing a polypeptide having both biological activity and flavor properties from Inner Mongolia milk tofu. It has been verified that the preparation method is simple and efficient, has strong real-time performance, reduces costs and manpower, and speeds up the preparation process. The method can also be used to separate polypeptides having both biological activity and flavor properties from other foods, especially fermented foods.
[0023] 3. The present invention proposes a method for artificially extracting and synthesizing multifunctional peptides from Inner Mongolia milk tofu. The method is simple and convenient, and can effectively save the synthesis cost of the polypeptide by artificially synthesizing polypeptides having both biological activity and taste properties. The method has the advantages of good practicability, short preparation process time, low labor cost, and simple and convenient operation. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0025] Figure 1 The number of polypeptides identified for the cheese of the present invention;
[0026] Figure 2 The peptide chain length (a) and molecular weight distribution diagram (b) of the identified polypeptides in the cheese of the present invention;
[0027] Figure 3 The results of the screening of potential flavor peptides of the present invention, wherein a is the screening result of umami peptides, b is the screening result of bitter peptides, and c is the peptide chain length distribution diagram of flavor peptides;
[0028] Figure 4 is the result of screening potential bioactive peptides of the present invention, wherein a is the number of potential ACE inhibitory peptides and potential antioxidant peptides, b is the peptide chain length distribution of potential polypeptides with both ACE inhibitory activity and antioxidant activity, and c is the molecular weight distribution of potential polypeptides with both ACE inhibitory activity and antioxidant activity;
[0029] Figure 5 is the antioxidant activity of the synthetic polypeptide of the present invention, wherein a is the DPPH free radical scavenging rate, and b is the ABTS free radical scavenging rate;
[0030] Figure 6 It is the ACE inhibitory activity of the synthetic polypeptide of the present invention. DETAILED DESCRIPTION
[0031] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0032] It should be understood that the terms described in the present invention are only for describing special embodiments and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. Each smaller range between the intermediate value in any stated value or stated range and any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0033] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0034] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present application description and examples are exemplary only.
[0035] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0036] The technical solutions described in the present invention, unless otherwise specified, are all conventional solutions in the art, and the reagents or raw materials used, unless otherwise specified, are purchased from commercial channels or are publicly available.
[0037] The embodiment of the present invention provides a polypeptide derived from Inner Mongolia milk tofu having antioxidant activity, antihypertensive activity and flavor characteristics, wherein the multi-active polypeptide is YPFPGPIH, IPYVRYL or VMFPPQ.
[0038] The YPFPGPIH and IPYVRYL provided by the present invention have bitter taste, and the threshold values are 0.03mmol / L and 0.06mmol / L, respectively. VMFPPQ has multiple taste attributes, including umami, bitterness and richness, among which umami is more prominent, and the threshold value is 0.81mmol / L.
[0039] YPFPGPIH, IPYVRYL and VMFPPQ all have good ACE inhibitory activity; YPFPGPIH and VMFPPQ have good antioxidant activity.
[0040] The peptides YPFPGPIH, IPYVRYL and VMFPPQ, which have both biological activity and taste properties, are used to prepare functional foods, condiments, food additives, medicines, etc. At the same time, they interact with the various components of food to produce rich flavors.
[0041] The present invention also provides a method for preparing the polypeptide, comprising the following steps:
[0042] Step1. Take Inner Mongolia milk tofu, crush it and set aside;
[0043] Step 2. The ground milk tofu powder is subjected to water extraction to obtain a water-soluble extract;
[0044] Step 3. Filter the water-soluble extract of Inner Mongolia milk tofu and analyze and identify its amino acid sequence;
[0045] Step 4. Calculate the Q value of the identified peptides, predict the umami / bitter and kokumi properties, and use molecular docking to screen peptides that bind to umami, bitter and kokumi receptors to obtain potential flavor peptides;
[0046] Step 5. Input the amino acid sequence of the peptide into the online website ToxinPred to predict the toxicity of the peptide; predict the ACE inhibitory activity using the antihypertensive database; predict the antioxidant activity using the AnOxPP and AnOxPePred online websites; based on the prediction score and taste prediction, screen for potential peptides with both biological activity and taste activity;
[0047] Step 6. Use solid phase synthesis to synthesize the polypeptide with a purity of >98%.
[0048] In some specific embodiments, the method of taking Inner Mongolia milk tofu and crushing it for later use is as follows:
[0049] Step 101. Remove the packaging of fresh Inner Mongolian milk tofu and cut into 1cm pieces 3 Blocky;
[0050] Step 102. Freeze the Inner Mongolian milk tofu in a -80°C refrigerator for 12 hours and perform vacuum freeze drying for 48 hours;
[0051] Step 103. Grind the freeze-dried Inner Mongolian milk tofu with a grinder, seal and store away from light for later use.
[0052] In some specific embodiments, the water extraction method is specifically:
[0053] Step 201. Mix the milk tofu sample and ultrapure water by vortexing, and then bathe and centrifuge the mixture;
[0054] Step 202. Take the supernatant, adjust its pH value to 4.6, precipitate soluble casein, and collect the supernatant by centrifugation.
[0055] In some specific embodiments, the solid-liquid ratio of the milk tofu sample to ultrapure water is 1:5; the water bath condition is 40°C 200rpm condition shaking reaction for 1h; the centrifugation condition is 9000rpm at 4°C for 20min; and the pH value is adjusted to 4.6 by using 1M hydrochloric acid to adjust the pH.
[0056] In some specific embodiments, the filtering of the water-soluble extract of Inner Mongolia milk tofu is specifically: filtering the water-soluble extract of Inner Mongolia milk tofu through a 0.45 μm membrane filter, and freeze-drying the components by vacuum freezing; after the freeze-dried material is re-dissolved and desalted, the peptide sequence and molecular weight are analyzed and identified by Easy nLC1200 / Q Exactive plus.
[0057] In some specific embodiments, the chromatographic conditions of the Easy nLC1200 / Q Exactive plus are:
[0058] (1) C18 reverse phase analytical column;
[0059] (2) Mobile phase A was 0.1% formic acid in water, mobile phase B was a mixture of 80% acetonitrile and 0.1% formic acid, and the flow rate was 300 nL / min;
[0060] (3) Gradient elution program: 0-3 min, 2-6% B; 3-42 min, 6-20% B; 42-47 min, 20-35% B; 47-48 min, 35-100% B; 48-60 min, 100% B;
[0061] (4) Mass spectrometry conditions were: ESI+ mode; orbital trap resolution 70000 (AGC 3e6); scanning range 350-1800 m / z.
[0062] In some specific embodiments, the prediction of umami / bitter and kokumi properties is specifically as follows: the amino acid sequence of the peptide is input into the iUmami-SCM, Umami_YYDS, UMPred-FPL, Tastepeptides_DM and iBitter-SCM websites to predict umami / bitter taste, and its kokumi properties are predicted by combining molecular docking and estimation based on conserved sites.
[0063] In some specific embodiments, in Step 4, the screening to obtain potential taste peptides is specifically:
[0064] Step 401. Select the top 500 peptides for the screening of flavor peptides. Calculate the Q value of the identified potential flavor peptides, and input the amino acid sequence of the peptides into the iUmami-SCM, Umami_YYDS, UMPred-FPL, Tastepeptides_DM and iBitter-SCM websites to predict flavor properties;
[0065] Step 402. Use Smina as the docking software, and use the active pocket of CASR as the center of the docking box with parameters of center-x=180, center-y=45, center-z=167; combine molecular docking and predict its kokumi properties based on conserved site estimation.
[0066] In some specific embodiments, in Step 5, the ACE inhibitory activity is predicted using an antihypertensive database as follows:
[0067] The prediction was made using a manually edited and experimentally validated antihypertensive database developed by Kumar et al., which includes the ACEpepDB, BIOPEP, and EROP-Moscow databases. Kumar et al. developed a web-based platform based on the database for predicting, designing, and screening antihypertensive peptides.
[0068] In some specific embodiments, in Step 5, the screening of potential polypeptides having both biological activity and taste activity is specifically:
[0069] Step 501. Input the amino acid sequences of the top 500 peptides into the online website ToxinPred to predict the toxicity of the peptides.
[0070] Step 502. ACE inhibitory activity was based on the manually edited experimentally verified antihypertensive database developed by Kumar et al., which includes ACEpepDB, BIOPEP, EROP-Moscow databases and published literature. Kumar et al. developed a web-based platform based on the database for predicting, designing and screening antihypertensive peptides. SVW>1 was selected to screen potential ACE inhibitory peptides.
[0071] Step 503. Antioxidant activity was predicted using the online websites AnOxPP and AnOxPePred (https: / / services.healthtech.dtu.dk / services / AnOxPePred-1.0 / ). The prediction scores were sorted from high to low, and the ACE inhibitory activity and taste properties were combined to screen for potential peptides with both biological activity and taste activity.
[0072] The embodiment of the present invention also provides the use of the polypeptide in preparing food flavoring.
[0073] The embodiment of the present invention also provides the use of the polypeptide in preparing an antioxidant.
[0074] The embodiment of the present invention also provides the use of the polypeptide in preparing a drug for preventing and treating hypertension.
[0075] The embodiment of the present invention also provides a product for food seasoning, comprising the polypeptide.
[0076] Example 1
[0077] A method for extracting and identifying a polypeptide having both biological activity and flavor properties from Inner Mongolia milk tofu, comprising the steps of: Step 1. taking fresh and clean Inner Mongolia milk tofu, crushing it for later use;
[0078] Step 101. Remove the packaging of fresh Inner Mongolian milk tofu and cut into 1cm pieces 3 Blocky;
[0079] Step 102. Freeze the Inner Mongolian milk tofu in a -80°C refrigerator for 12 hours and perform vacuum freeze drying for 48 hours;
[0080] Step 103. Grind the freeze-dried Inner Mongolian milk tofu with a grinder, seal and store away from light for later use.
[0081] Step 2. Use water extraction method to obtain water-soluble extract from the ground milk tofu powder
[0082] Step 201. Mix the milk tofu sample with ultrapure water at a solid-liquid ratio of 1:5 and vortex. Oscillate the mixture in a water bath shaker at 40°C and 200 rpm for 1 hour, and then centrifuge at 9000 rpm for 20 minutes at 4°C.
[0083] Step 202. Take the supernatant, adjust its pH to 4.6 with 1M hydrochloric acid to precipitate soluble casein, centrifuge at 9000 rpm and 4°C for 20 min, and collect the supernatant.
[0084] Step 3. Filter the water-soluble extract of Inner Mongolia milk tofu and analyze and identify its amino acid sequence
[0085] Step 301. Filter the milk tofu water-soluble extract through a 0.45 μm membrane filter, freeze-dry the components by vacuum freezing, and store at -80°C for later use;
[0086] Step 302. The freeze-dried product was reconstituted and desalted, and then analyzed by Easy nLC1200 / Q Exactive plus to identify the peptide sequence and molecular weight;
[0087] The chromatographic conditions of Easy nLC1200 / Q Exactive plus are:
[0088] (1) C18 reverse phase analytical column;
[0089] (2) Mobile phase A was 0.1% formic acid in water, mobile phase B was a mixture of 80% acetonitrile and 0.1% formic acid, and the flow rate was 300 nL / min;
[0090] (3) Gradient elution program: 0-3 min, 2-6% B; 3-42 min, 6-20% B; 42-47 min, 20-35% B; 47-48 min, 35-100% B; 48-60 min, 100% B;
[0091] (4) Mass spectrometry conditions were: ESI+ mode; orbital trap resolution 70000 (AGC 3e6); scanning range 350-1800 m / z;
[0092] Step 303. Use Peaks 10.0 software search engine to perform sequence analysis on the test sample data. 2580 peptides were determined in three parallel runs. The molecular weights of the identified peptides were concentrated between 500-1500 Da, and the peptide chain lengths were mainly concentrated between 6-14 amino acid residues. The results are as follows: Figure 1-2 shown.
[0093] Example 2
[0094] Different from Example 1, the process of predicting and screening the potential polypeptides having both biological activity and flavor properties of Inner Mongolia milk tofu includes the following steps:
[0095] Step 4. Calculate the Q value of the identified peptides and input the amino acid sequence of the peptides into the iUmami-SCM, Umami_YYDS, UMPred-FPL, Tastepeptides_DM and iBitter-SCM websites to predict umami / bitter taste; combine molecular docking and predict its kokumi properties based on conserved site estimation to screen potential flavor peptides;
[0096] Step 401. Select the top 500 peptides for the screening of flavor peptides. Calculate the Q value of the identified potential flavor peptides, and input the amino acid sequence of the peptides into the iUmami-SCM, Umami_YYDS, UMPred-FPL, Tastepeptides_DM and iBitter-SCM websites to predict the flavor properties; specifically, Figure 2 As shown, there are 67 and 84 potential umami peptides and potential bitter peptides, respectively, with lengths ranging from 6 to 11 amino acid residues;
[0097] Step 402. Use Smina as docking software, take the active pocket of CASR as the docking box center, and its parameters are center-x=180, center-y=45, center-z=167; combine molecular docking and predict its kokumi properties based on conservative site estimation, specifically, Figure 3 As shown, there are 191 peptides that may have a thick feeling, and their lengths are concentrated between 6 and 10 amino acid residues;
[0098] Step 5. Enter the amino acid sequence of the peptide into the online website ToxinPred to predict the toxicity of the peptide. ACE inhibitory activity was predicted using the manually edited and experimentally verified antihypertensive database developed by Kumar et al., which includes ACEpepDB, BIOPEP and EROP-Moscow databases. Kumar et al. developed a web-based platform based on the database for predicting, designing and screening antihypertensive peptides. Antioxidant activity was predicted using the online websites AnOxPP and AnOxPePred. Based on the prediction score and taste prediction, potential peptides with both biological activity and taste activity were screened.
[0099] Step 501. Input the amino acid sequences of the top 500 peptides into the online website ToxinPred to predict the toxicity of the peptides.
[0100] Step 502. ACE inhibitory activity was based on the manually edited experimentally verified antihypertensive database developed by Kumar et al., which includes ACEpepDB, BIOPEP, EROP-Moscow databases and published literature. Kumar et al. developed a web-based platform based on the database for predicting, designing and screening antihypertensive peptides. SVW>1 was selected to screen potential ACE inhibitory peptides.
[0101] Step 503. Antioxidant activity was predicted using the online websites AnOxPP and AnOxPePred (https: / / services.healthtech.dtu.dk / services / AnOxPePred-1.0 / ). The prediction scores were sorted from high to low, and the potential peptides with both biological activity and flavor activity were screened in combination with ACE inhibitory activity and flavor properties. The prediction results are as follows: Figure 4 As shown, there are 160 and 148 peptides that may have ACE inhibitory activity and antioxidant activity, respectively. Among them, there are 82 peptides that have both ACE inhibitory activity and antioxidant activity. The molecular weight is concentrated in the range of 500-1500Da, and the peptide chain length is mostly 6 to 8 amino acid residues.
[0102] Specifically, combining the prediction of flavor attributes and biological activity, the final multifunctional peptide screening results are shown in Table 1. Three potential multifunctional peptides were screened out, namely, peptides with ACE inhibitory activity, antioxidant activity and flavor attributes, among which YH8 and IL7 may have bitterness and richness, and the taste attributes of VQ6 may be umami, bitterness and richness.
[0103] Table 1: Potential peptides with biological activity and taste properties
[0104]
[0105] Example 3
[0106] Different from the above examples, in order to verify the taste properties of the three peptides YPFPGPIH, IPYVRYL and VMFPPQ, this example was designed to synthesize the peptides and evaluate their taste properties, including
[0107] Step 6. Synthesis of peptides with both biological activity and flavor properties and evaluation of flavor properties
[0108] Step 601. Use solid phase synthesis to synthesize potential peptides with multiple activities and taste properties. Shanghai Jier Biochemical Co., Ltd. is commissioned to perform solid phase synthesis of YPFPGPIH (Tyr-Pro-Phe-Pro-Gly-Pro-Ile-His), IPYVRYL (Ile-Pro-Tyr-Val-Arg-Tyr-Leu) and VMFPPQ (Val-Met-Phe-Pro-Pro-Gln), with a purity greater than 98%;
[0109] Step 602. The evaluation team consisted of 10 sensory evaluators (6 females and 4 males, aged 22-29 years old). All team members received sensory training based on GB / T 16291.1-2012 to distinguish the five basic tastes (sour, sweet, bitter, salty, and fresh) and the sense of richness. The team members performed a taste description analysis on the synthetic peptide solution and used the triangle test method to determine the taste threshold of each synthetic peptide. According to the preliminary experiment, YPFPGPIH and IPYVRYL have a single strong bitter taste and a low bitterness threshold. Therefore, YPFPGPIH and IPYVRYL were prepared with synthetic peptide solutions of initial concentrations of 0.125 mg / mL and 0.25 mg / mL, respectively; VMFPPQ was prepared with a synthetic peptide solution of an initial concentration of 2 mg / mL. The synthetic peptide solution was adjusted to 4.6 according to the pH value of the water-soluble extract and diluted stepwise at 1:1 (v / v). The samples after the stepwise dilution were assigned to the sensory officials for evaluation in the order of increasing concentration. The sensory officials were required to select samples with taste differences from 3 cups of solution (1 cup of sample solution and 2 cups of ultrapure water solution) and describe their taste attributes. The samples were randomly coded with three digits. The umami threshold of the synthetic peptide was the geometric mean of the individual thresholds of the panel members.
[0110] Step 603. The sensory evaluation results of the synthetic peptides are shown in Table 2. All three synthetic peptides have taste attributes, among which YH8 and IL7 are bitter, and the bitterness thresholds are 0.03mmol / L and 0.06mmol / L, respectively; VQ6 has umami, bitterness and richness, among which the umami taste is more prominent, and the umami threshold is 0.81mmol / L.
[0111] Table 2: Sequences, taste descriptions and main taste thresholds of synthetic peptides
[0112]
[0113] Example 4
[0114] Different from the above examples, in order to verify the antioxidant activity and ACE inhibitory activity of the three peptides YPFPGPIH, IPYVRYL and VMFPPQ, this example is designed to verify the in vitro antioxidant activity and ACE inhibitory activity of the peptides, including
[0115] Step 7. Determination of the antioxidant activity of the three peptides using the DPPH and ABTS methods
[0116] Step 701. Prepare peptide solutions of YPFPGPIH, IPYVRYL and VMFPPQ with concentrations of 0.5 mg / mL, 1 mg / mL, 2 mg / mL, 5 mg / mL, 10 mg / mL, 15 mg / mL and 20 mg / mL respectively for use;
[0117] Step 702. Determine the free radical scavenging activity by 1,1-diphenyl-2-trinitrohydrazine (DPPH). Mix 1 mL of DPPH solution (0.1 mM DPPH, dissolved in 95% ethanol) with 1.5 mL of synthetic peptides of different concentrations, vortex to mix, and incubate at room temperature in the dark for 30 min. 95% ethanol solution was used as a reference, and the absorbance of the incubated samples was measured at 517 nm. The DPPH free radical scavenging activity was calculated as follows:
[0118] DPPH free radical scavenging ability (%) = [1-(A1-A2) / A3] × 100%;
[0119] Among them: A1 - absorbance of sample and DPPH; A2 - absorbance of reaction between 95% ethanol and sample; A3 - absorbance of reaction between distilled water and DPPH solution.
[0120] Step 703. ABTS + The solution (7.0 mM) was added to an equal volume of potassium persulfate (2.45 mM) and incubated in the dark at room temperature for 12-16 h. Before use, the ABTS solution was diluted with 95% ethanol. + The solution was prepared so that its absorbance at 734 nm was 0.70 ± 0.02, and ABTS· + Working solution. Add 500 μL of sample and 500 μL of diluted ABTS working solution respectively, react at room temperature for 10 minutes, pipette 200 μL into a 96-well plate, and measure the absorbance at 734 nm. Set up three parallel experiments for each group. ABTS scavenging activity is calculated as follows:
[0121] ABTS free radical scavenging ability (%) = [1-(A1-A2) / A3] × 100%;
[0122] Among them: A1--the absorbance of the sample; A2--the absorbance of the reaction between 95% ethanol and the sample; A3--the absorbance of the reaction between distilled water and ABTS solution.
[0123] Step 704. Determine the antioxidant activity of the three peptides at seven concentrations, draw curves and calculate IC 50 value.
[0124] Step 8. Using hippocampal histidyl leucine (HHL) to determine the ACE inhibitory activity of the three peptides
[0125] Step 801. Prepare solutions of YPFPGPIH and IPYVRYL with concentrations of 0.0625 mg / mL, 0.125 mg / mL, 0.25 mg / mL, 0.5 mg / mL, 1 mg / mL and 2 mg / mL, respectively, and prepare solutions of VMFPPQ with concentrations of 0.15625 mg / mL, 0.3125 mg / mL, 0.625 mg / mL, 1.25 mg / mL, 2.5 mg / mL and 5 mg / mL;
[0126] Step802. Pre-incubate 20 μL of sample with 10 μL ACE (0.1 U / mL) at 37°C for 10 min. Then incubate the mixture with 50 μL of substrate solution containing 5 mM HHL buffer (pH 8.3) and 300 mM sodium chloride at 37°C for 60 min. Except for the blank control (75 μL 1M HCl was added before pre-incubation), 75 μL 1M HCl was added to all samples to terminate the reaction. Hippuric acid was extracted with 1 mL of ethyl acetate, vortexed for 30 s, centrifuged (4000 r / min, 10 min, 4°C), and allowed to stand to separate the aqueous phase from the organic phase, collect all the ethyl acetate layers, and evaporate the ethyl acetate in a 110°C oven for 30 min. The residue was dissolved in 1.0 mL of ultrapure water, and the absorbance at 228 nm was measured using a UV spectrophotometer. ACE inhibitory activity was determined according to the following formula:
[0127] ACE inhibition rate (%) = [(A1-A2) / (A1-A0)] × 100%;
[0128] Where A1 is the absorbance when no sample solution is added, and borate buffer is used instead of sample; A2 is the absorbance when ACE and sample solution are present; A0 is the absorbance of the positive control, and 75 μL of hydrochloric acid has been added before adding ACE;
[0129] Step 803. Determine the ACE inhibitory activity of the three peptides at six concentrations, draw curves and calculate IC 50 value.
[0130] The antioxidant activity and ACE inhibitory activity of the three synthetic peptides YPFPGPIH, IPYVRYL and VMFPPQ were verified according to the above experimental methods, as shown in Table 3 and Figure 5-6 The results showed that YPFPGPIH and VMFPPQ had good antioxidant properties, and the IC values of DPPH free radical scavenging ability were 50 The values were 1.44 and 1.33 mg / mL, respectively. The ACE inhibition rates IC of YPFPGPIH, IPYVRYL, and VMFPPQ 50 The values were 0.30, 0.07 and 1.01 mg / mL respectively.
[0131] Table 3: Antioxidant activity and ACE inhibitory activity values of synthetic peptides
[0132]
[0133] Note: “-” indicates that IC was not detected within the concentration range 50 value.
[0134] Obviously, the above embodiments of the present invention are merely examples for clearly explaining the present invention, and are not intended to limit the implementation methods of the present invention. For ordinary technical users in the relevant field, other different forms of changes or modifications can be made on the basis of the above description. It is not necessary and impossible to list all the implementation methods here. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the claims of the present invention.
Claims
1. A polypeptide having antioxidant activity, antihypertensive activity and flavor properties derived from Inner Mongolia milk tofu, characterized in that: The multi-active polypeptide is YPFPGPIH, IPYVRYL or VMFPPQ.
2. The method for preparing the polypeptide according to claim 1, characterized in that: The following steps are involved: Step1. Take Inner Mongolia milk tofu, crush it and set aside; Step 2. The ground milk tofu powder is subjected to water extraction to obtain a water-soluble extract; Step 3. Filter the water-soluble extract of Inner Mongolia milk tofu and analyze and identify its amino acid sequence; Step 4. Calculate the Q value of the identified peptides, predict the umami / bitter and kokumi properties, and use molecular docking to screen peptides that bind to umami, bitter, and kokumi receptors to obtain potential flavor peptides; Step 5. Input the amino acid sequence of the peptide into the online website ToxinPred to predict the toxicity of the peptide; predict the ACE inhibitory activity using the antihypertensive database; predict the antioxidant activity using the AnOxPP and AnOxPePred online websites; based on the prediction score and taste prediction, screen for potential peptides with both biological activity and taste activity; Step 6. Use solid phase synthesis to synthesize the polypeptide with a purity of >98%.
3. The preparation method according to claim 2, characterized in that: The water extraction method is specifically: Step 201. Mix the milk tofu sample and ultrapure water, vortex, and bathe and centrifuge the mixture; Step 202. Take the supernatant, adjust its pH value to 4.6, precipitate soluble casein, and collect the supernatant by centrifugation.
4. The preparation method according to claim 3, characterized in that: The liquid-to-solid ratio of the milk tofu sample to ultrapure water is 1:5; the water bath condition is 40°C 200rpm shaking reaction for 1h; the centrifugation condition is 4°C 9000rpm centrifugation for 20min; the pH value is adjusted to 4.6 by using 1M hydrochloric acid to adjust the pH.
5. The preparation method according to claim 2, characterized in that: The filtering of the water-soluble extract of Inner Mongolian milk tofu is specifically as follows: filtering the water-soluble extract of Inner Mongolian milk tofu through a 0.45 μm membrane filter, freeze-drying the components by vacuum freezing; and analyzing and identifying the peptide sequence and molecular weight of the freeze-dried product by Easy nLC1200 / Q Exactive plus after redissolution and desalting.
6. The preparation method according to claim 5, characterized in that: The chromatographic conditions of the Easy nLC1200 / Q Exactive plus are: (1) C18 reverse phase analytical column; (2) Mobile phase A was 0.1% formic acid in water, mobile phase B was a mixture of 80% acetonitrile and 0.1% formic acid, and the flow rate was 300 nL / min; (3) Gradient elution program: 0-3 min, 2-6% B; 3-42 min, 6-20% B; 42-47 min, 20-35% B; 47-48 min, 35-100% B; 48-60 min, 100% B; (4) Mass spectrometry conditions were: ESI+ mode; orbital trap resolution 70000 (AGC 3e6); scanning range 350-1800 m / z.
7. Use of the polypeptide as claimed in claim 1 in preparing food flavoring.
8. Use of the polypeptide according to claim 1 in the preparation of antioxidants.
9. Use of the polypeptide according to claim 1 in the preparation of drugs for preventing and treating hypertension.
10. A product for food seasoning, characterized in that: Comprising the polypeptide of claim 1.
Citation Information
Patent Citations
Method for preparing antioxidant peptides from yak cheese protein
CN102787156A
Preparation method and applications of camel milk antioxidant polypeptides
CN109180788A
Preparation method of multifunctional active lactobacillus beverage taking whey water as raw material
CN115413713A
Agaricus bisporus umami peptide and prediction and screening method thereof
CN116655735A
Umami peptide based on artificial intelligence screening, screening method and application
CN117510586A
